Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now ...

Tiny gold particles that act as carriers for lithium can be delivered directly to the brain in the form of a nasal spray.

Molecular dynamics simulations have emerged as an indispensable tool in modern biomedical research, particularly in the study of protein kinases. This computational approach permits detailed ...

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces final trial results ...

A study in Advanced Science has pinpointed how a high-salt diet can lead to cognitive decline. Researchers found excess salt ...

A recent study conducted by researchers at Queen Mary University of London unveiled a new mechanism through which cells ...

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ...

The ALBORADA Drug Discovery Institute, University of Cambridge, Cambridge, United Kingdom ...

In the form of a 'nasal spray', tiny gold particles act as carriers, delivering a treatment directly to the brain: developed by scientists at the Università Rome campus/Fondazione Policlinico ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $28.0, a high estimate of $34.00, and a low estimate of $16.00. Highlighting a 6.67% decrease, ...

Rapamycin became a billion-dollar drug, but many of the people instrumental to its discovery—including the people of Rapa Nui ...